We have supported some of the largest real world evidence gathering programmes for postmarketing commitments but also for enhanced reimbursment.
The EU is moving forward with key upgrades to its medical device and diagnostics regulations, specifically under the Medical Device…
Gene therapies now account for most ATMP clinical trials, with a balanced distribution between in vivo and ex vivo approaches.…
Academic medical centers in the US are voicing concern over reduced funding from the National Institutes of Health (NIH). While…
Copyright @ 2025 Axcellant